Increased cancer risk among relatives of nonsmoking lung cancer cases

Genetic Epidemiology

Volumn 17, Issue 1, 1999, Pages 1-15

  Schwartz, Ann G ^a,d   Rothrock, Michael ^a   Yang, Ping ^b   Swanson, G Marie ^c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Familial aggregation; Lung cancer; Tobacco exposure

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; DATA ANALYSIS; FAMILIAL CANCER; FEMALE; GENETIC PREDISPOSITION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SMOKING HABIT; TOBACCO;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; INTERVIEWS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MICHIGAN; MIDDLE AGED; NEOPLASMS; QUESTIONNAIRES; RISK FACTORS;

NICOTIANA TABACUM;

EID: 0032842734     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2272(1999)17:1<1::AID-GEPI1>3.0.CO;2-C     Document Type: Article

References (58)

1. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, et al. 1995. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 55:3483-3485.
2. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, et al. 1996. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. J Am Med Assoc 276:1494-1501.
3. Anderson KE, Woo C, Olson J, Sellers TA, Zheng W, Kushi LH, et al. 1997. Association of family history of cervical, ovarian, and uterine cancer with histological categories of lung cancer: the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prevention 6: 401-405.
4. Bondy ML, Strom SS, Colopy MW, Brown BW, Strong LC. 1994. Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma. J Clin Epidemiol 47:89-96.
5. Bouchardy C, Benhamou S, Dayer P. 1996. The effects of tobacco on lung cancer risk depends on CYP2D6 activity. Cancer Res 56: 251-253.
6. Bubb VJ, Curtis LJ, Cunningham C, Dunlop MG, Carothers AD, Morris RG, et al. 1996. Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer. Oncogene 12: 2641-2649.
7. Caporaso N, Goldstein A. 1995. Cancer genes: single and susceptibility: exposing the difference. Pharmacogenetics 5: 59-63.
8. Caporaso N, DeBaum MR, Rothman N. 1995. Lung cancer and CYP2D6 (the debrisoquine polymorphism): sources of heterogeneity in the proposed association. Pharmacogenetics 5:S129-134.
9. Cascorbi I, Brockmuller J, Mrozikiewicz PM, Bauer S, Loddenkemper R, Roots I. 1996. Homozygous rapid arylamine N-actyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res 56:3961-3966.
10. Cavenee WK, Koufos A, Hansen MF. 1986. Recessive mutant genes predisposing to human cancer. Mutat Res 168:3-14.
11. Cosma G, Crofts F, Currie D, Wirgin I, Toniolo P, Garte SJ. 1993. Racial differences in restriction fragment length polymorphisms and messenger RNA inducibility of the human CYP1A1 gene. Cancer Epidemiol Biomarkers Prev 2: 53-57.
12. Fong KM, Zimmerman PV, Smith PJ. 1995. Microsatellite instability and other molecular abnormalities in non-small cell lung cancer. Cancer Res 55:28-30.
13. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE, Breast Cancer Linkage Consortium. 1994. Risks of cancer in BRCA-1 mutation carriers. Lancet 343:692-695.
14. Gauderman WJ, Morrison JL, Carpenter CL, Thomas DC. 1997. Analysis of gene-smoking interaction in lung cancer. Genet Epidemiol 14:199-214.
15. Giardiello FM. 1997. Genetic testing in hereditary colorectal cancer. J Am Med Assoc 278:1278-1281.
16. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. 1994. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600-1608.
17. Hirvonen A, Husgafvel-Pursianinen K, Antilla S, Karjolainen A, Sorsa M, Vainio H. 1992. Metabolic cytochrome P450 genotypes and assessment of individual susceptibility to lung cancer. Pharmacogenetics 2:259-263.
18. Hirvonen A, Pelin K, Tammilehto L, Karjalainen A, Mattson K, Linnainmaa K. 1995. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res 55: 2981-2983.
19. Houlston RS, Peto J. 1996. Genetics and the common cancers. In: Eeles RA, Ponder BAJ, Easton DF, Horwich A, editors. Genetic predisposition to cancer.London: Chapman & Hall, p 208-226.
20. Illis WR, Swanson GM, Satariano ER, Schwartz AG. 1987. Summary measures of occupational history: a comparison of latest occupation and industry with usual occupation and industry. Am J Public Health 77:1532-1534.
21. Kawajiri K, Natachi K, Luai K, Yoshi A, Shinodo N, Watanabe J. 1990. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett 263:131-133.
22. Li FP, Fraumeni JF Jr. 1969. Soft-tissue sarcomas, breast cancer, and other neoplasms: a familial syndrome? Ann Intern Med 71:747-752.
23. Love RR, Evans AM, Josten DM. 1985. The accuracy of patient reports of a family history of cancer. J Chronic Dis 38:289-293.
24. Lui B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, et al. 1996. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nature Med 2:169-174.
25. Malkin D, Li FP, Strong LC, Fraumeni J Jr., Nelson CE, Kim D, et al. 1990. Germ line p53 mutations in a familial syndrome of breast cancer sarcomas and other neoplasms. Science 250:1233-1238.
26. McLaughlin JK, Dietz MS, Mehl ES, Blot WJ. 1987. Reliability of surrogate information on cigarette smoking by type of informant. Am J Epidemiol 126:144-146.
27. Merlo A, Mabry M, Gabrielson E, Vollmer R, Baylin SB, Sidransky D. 1994. Frequent microsatellite instability in primary small cell lung cancer. Cancer Res 54: 2098-2101.
28. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian A, et al. 1994. Isolation of BRCA1, the 17q-linked breast and ovarian cancer susceptibility gene. Science 266: 66-71.
29. Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K. 1991. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 51:5177-5180.
30. Nakajima T, Elovaara E, Antilla S, Hirvonen A, Camus AM, Hayes JD, et al. 1995. Expression and polymorphisms of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis 16:707-711.
31. Nazar-Stewart V, Motulsky AG, Eaton DL, White E, Hornung SK, Leng Z-T, et al. 1993. The glutathione S-transferase m polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 53: 2313-2318.
32. Nelson CL, Sellers TA, Rich SS, Potter JD, McGovern PG, Kushi LH. 1993. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history. Genetic Epidemiol 10:235-244.
33. Olschwang S, Laurent-Puig P, White GR, Thomas G. 1993. Germ-line mutations in the first 14 exons of the adenomatous polyposis coli gene (APC). Am J Human Genet 52:269-273.
34. Ooi WL, Elston RC, Chen VW, BaileyWilson JE, Rothschild H. 1986. Increased familial risk for lung cancer. J Natl Cancer Inst 76:217-222.
35. SAS Institute Inc. 1990. SAS/STAT User's Guide, Version 6, Fourth Edition, Volumes 1-2. Cary, NC: SAS Institute Inc.
36. SAS Institute Inc. 1997. SAS/STAT Software: changes and enhancements through release 6.12. Cary, NC: SAS Institute Inc.
37. Schwartz AG, Boehnke M, Moll PP. 1988. Family risk index as a measure of familial heterogeneity of cancer risk: a population-based study in metropolitan Detroit. Am J Epidemiol 128:524-535.
38. Schwartz AG, Yang P, Swanson GM. 1996. Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol 144:554-562.
39. Seigegard J, Pero RW, Markowitz MM, Roush G, Miller DG, Beattie EJ. 1990. Isoenzymes of glutathione transferase (class mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis 11:33-36.
40. Sellers TA, Ooi WL, Elston RC, Chen VW, BaileyWilson JE, Rothschild H. 1987. Increased familial risk for nonlung cancer among relatives of lung cancer patients. Am J Epidemiol 126:237-246.
41. Sellers TA, Elston RC, Stewart C, Rothschild H. 1988. Familial risk of cancer among randomly selected cancer probands. Genetic Epidemiol 5: 381-391.
42. Sellers TA, Bailey-Wilson JE, Elston RC, Wilson AF, Ooi WL, Rothschild H. 1990. Evidence for Mendelian inheritance in the pathogenesis of lung cancer. J Natl Cancer Inst 82:1272-1279.
43. Sellers TA, Potter JD, Folsom AR. 1991. Association of incident lung cancer with family history of female reproductive cancers: the Iowa Women's Health Study. Genetic Epidemiol 8:199-208.
44. Sellers TA, Chen P-L, Potter JD, Bailey-Wilson JE, Rothschild H, Elston RC. 1994. Segregation analysis of smoking-associated malignancies: evidence for Mendelian inheritance. Am J Med Genet 52:308-314.
45. Shaw GL, Falk RT, Pickle LW, Mason TJ, Buffler PA. 1991. Lung cancer risk associated with cancer in relatives. J Clin Epidemiol 44:429-437.
46. Shields PG, Caporaso NE, Falk RT, Sugimura H, Trivers GE, Trump BF, et al. 1993. Lung cancer, risk, and a CYP1A1 genetic polymorphism. Cancer Epidemiol Biomarkers Prev 2:481-485.
47. Shridhar V, Siegfried J, Hunt J, del Mar Alonso M, Smith D. 1994. Genetic instability of microsatellite sequences in many non-small cell lung carcinomas. Cancer Res 54:2084-2087.
48. Sugimura H, Hamada GS, Suzuki I, Iwase T, Kiyokawa E, Kino I, et al. 1995. CYP1A1 and CYP2E1 polymorphisms and lung cancer, a case-control study in Rio de Janeiro, Brazil. Pharmacogenetics 5:S145-148.
49. Swanson GM, Schwartz AG, Brown KL. 1985. Population-based occupational cancer incidence surveillance. J Occup Med 27: 439-444.
50. 1450) gene: lack of association between the MspI RFLP and incidence of lung cancer in a Norwegian population. Pharmacogenetics 1:20-25.
51. Vineis P, Martone T. 1995. Genetic-environmental interactions and low-level exposure to carcinogens. Epidemiol 6:455-457.
52. Watson P, Lynch HT 1994. The tumor spectrum in HNPCC. Anticancer Res 14:1635-1640.
53. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. 1995. Identification of the breast cancer susceptibility gene BRCA2. Nature 387:789-792.
54. Wu AH, Fontham ETH, Reynolds P, Greenberg RS, Buffler P, Liff J, et al. 1996. Family history of cancer and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 143:535-542.
55. Yang P, Romkes M, Schwartz AG, Rittmeyer L, Adedoyin A, Landreneau R, et al. 1996. Polymorphisms at the NAT2* locus associated with increased cancer risk in first-degree relatives of lung cancer patients. Genetic Epidemiol 3:308-309.
56. Yang P, Schwartz AG, McAllister AE, Swanson GM, Aston CE. 1999. Lung cancer risk in families of nonsmoking probands: heterogeneity by age at diagnosis. Genetic Epidemiol.
57. Zeger SL, Liang KY. 1986. Longitudinal data analysis for discrete continuous outcomes. Biometrics 42:121-130.
58. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. 1993. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14:1821-1824.